For instance, of 65 known TP53 carriers with breast cancer in the Genomic Medicine Centre in Manchester 32/65 occurred aged <31 (49%), 24 (37%) occurred aged 31–39, 5 (7.5%) aged 40–44 and only 3/65 (4.5%) over age 45. This evidence concerns the gene TP53 and breast cancer.